Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nano carrier for inhibiting angiogenesis through targeting VEGFA via HIF1a activation in Breast cancer cell (MCF-7)

Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nano carrier for inhibiting angiogenesis through targeting VEGFA via HIF1a activation in Breast cancer cell (MCF-7)


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سید امیر شکوری - بیوتکنولوژیست , هومن کهربا , حامد همیشه کار , جلال عبدالعلیزاده

کلمات کلیدی: Angiogenesis Breast cancer Leech saliva extract Liposome Nano drug VEGFA

نشریه: 4593 , 2 , 12 , 2022

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله جلال عبدالعلیزاده
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 74814
عنوان فارسی مقاله Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nano carrier for inhibiting angiogenesis through targeting VEGFA via HIF1a activation in Breast cancer cell (MCF-7)
عنوان لاتین مقاله Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nano carrier for inhibiting angiogenesis through targeting VEGFA via HIF1a activation in Breast cancer cell (MCF-7)
ناشر 4
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nano carrier for inhibiting angiogenesis through targeting VEGFA via HIF1a activation in Breast cancer cell (MCF-7) Introduction: Breast cancer is the most serious cause of women’s death throughout the world. Using nanocarrier vehicles to the exact site of cancer upgrades the therapeutic efficiency of the drugs. Capsulation of active proteins in the vesicular liposomes’ hydrophilic core is essential to develop a therapeutic protein carrier system. We aimed to encapsulate the medicinal leech saliva extract (LSE) and assess the inhibition of angiogenesis of breast cancer cells by targeting vascular endothelial growth factor A (VEGFA). Methods: In this research, enhanced formulation of liposomal protein was determined by zeta potential analysis, droplet size, drug release assay, and transmission electron microscopy (TEM). Furthermore, a cytotoxicity assay of liposomal LSE was performed to determine the cytotoxic activity of components. For assessing the expression of VEGFA, P53, and hypoxia-inducible factor subunit alpha (HIF1a) genes, Real-Time PCR was applied. Results: Nano liposome was chosen as an enhanced formulation due to its much smaller size (46.23 nm). Liposomal LSE had more practical actions on the MCF-7 cells. As noticed by DAPI staining, apoptosis was extensively greater in treated MCF-7 cells. Wound healing assay demonstrated that MCF-7 cells could not sustain growth at the presence of liposomal LSE and expression of the VEGFA gene was declined in treated cells. Downregulation of VEGFA was evaluated with western blotting technique. Conclusion: It can be concluded that our investigation of the tests confirmed the fact that nano liposomal LSE is a novel promising formulation for anticancer drugs and can significantly improve the penetration of protein drugs to cancer cells.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سید امیر شکوری - بیوتکنولوژیستاول
هومن کهربادوم
حامد همیشه کارسوم
جلال عبدالعلیزادهچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
bi-12-115.pdf1400/11/102850266دانلود